Diabetic Foods Market Report 2026

The diabetic foods market size has grown rapidly in recent years. It will grow from $14.77 billion in 2025 to $16.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of diabetes, increased health awareness among consumers, expansion of specialized health food retail, growth of preventive healthcare nutrition, improved availability of diabetic-friendly products.

The diabetic foods market size is expected to see rapid growth in the next few years. It will grow to $25.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for functional medical nutrition, rising adoption of personalized dietary solutions, expansion of online health food distribution, growing investment in nutraceutical innovation, increasing regulatory focus on nutritional labeling. Major trends in the forecast period include increasing development of low-glycemic food products, rising demand for sugar-free and low-carb alternatives, growing use of natural sweeteners in diabetic foods, expansion of personalized nutrition offerings, enhanced focus on clean-label formulations.

The rising incidence of juvenile diabetes among children and youth is expected to drive the growth of the diabetic food market in the coming years. Type 1 diabetes, also known as juvenile diabetes, is the most common form of diabetes among young individuals, accounting for approximately 90% of cases. Healthcare professionals often recommend the Mediterranean diet for managing type 1 diabetes. This diet is rich in nutrient-dense foods such as fresh vegetables, fruits like oranges, plant-based fats including olive oil and nuts, as well as fish like sardines, with occasional consumption of meat and dairy products. For instance, in June 2024, the National Health Service (NHS England) reported that in 2023, the number of individuals identified with pre-diabetes in England rose to 3,615,330, an 18% increase from 3,065,825 in 2022. Among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Consequently, the increasing number of juvenile diabetes cases is fueling the growth of the diabetic food market.

Leading companies in the diabetic food market are engaging in strategic partnerships to launch innovative programs such as What Can I Eat to better support diabetic patients. The What Can I Eat program is a nutrition education and food access initiative designed to help individuals with diabetes make healthy dietary choices. For example, in March 2023, the American Diabetes Association, a U.S.-based professional organization, partnered with Elevance Health Foundation, a U.S.-based healthcare foundation, to launch an enhanced version of the program. The initiative addresses social determinants of health that contribute to type 2 diabetes, supports sustainable behavioral changes, and provides free nutritious foods to tackle some of the core challenges faced by the diabetes community.

In August 2024, Abbott Laboratories, a U.S.-based healthcare company, collaborated with the American Diabetes Association to advance the understanding of nutrition formulas in supporting individuals with diabetes and obesity. The partnership aims to generate insights into nutritional management, improve patient outcomes, raise awareness of science-backed dietary solutions for managing diabetes and obesity, and foster innovation and growth in the medical nutrition market. The American Diabetes Association is a U.S.-based leading non-profit organization dedicated to preventing and curing diabetes and improving the lives of those affected by the condition.

Major companies operating in the diabetic foods market are Nestlé Health Science, Abbott Laboratories, Danone S.A., Fifty50 Foods Inc, Zen Health Japan Co Ltd, Zydus Wellness Ltd, Herbalife Nutrition Ltd, InBalance Health Corp, NaturesPlus, Orkla Health AS, Golden Farm Candies, Beneo GmbH, Arkopharma Laboratories, Glanbia Plc, Axiom Foods Inc, Vitasoy International Holdings Ltd, SunOpta Inc, The Hain Celestial Group Inc, Mars Incorporated, Kellogg Company.

Asia-Pacific was the largest region in the diabetic foods market in 2025. Western Europe was the second-largest region in the global diabetic foods market. The regions covered in the diabetic foods market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the diabetic foods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The diabetic foods market consists of sales of low-calorie sweeteners, diet beverages, and other diabetic foods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.